Yasuhiro Imaeda

1.5k total citations
30 papers, 1.1k citations indexed

About

Yasuhiro Imaeda is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yasuhiro Imaeda has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yasuhiro Imaeda's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Synthesis and Catalytic Reactions (4 papers) and Protein Degradation and Inhibitors (4 papers). Yasuhiro Imaeda is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Synthesis and Catalytic Reactions (4 papers) and Protein Degradation and Inhibitors (4 papers). Yasuhiro Imaeda collaborates with scholars based in Japan, United States and Canada. Yasuhiro Imaeda's co-authors include Nobuo Cho, Takayuki Hattori, Mikihiko Naito, Katsunori Nagai, Nobumichi Ohoka, Norihito Shibata, Hiroshi Nara, Masahiro Ito, Osamu Sano and Osamu Ujikawa and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Yasuhiro Imaeda

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Imaeda Japan 17 828 284 234 161 65 30 1.1k
Robert A. Galemmo United States 19 494 0.6× 158 0.6× 143 0.6× 262 1.6× 90 1.4× 46 1.0k
Butrus Atrash United Kingdom 18 767 0.9× 323 1.1× 90 0.4× 260 1.6× 100 1.5× 39 1.2k
Wen‐Hsing Lin Taiwan 19 569 0.7× 260 0.9× 111 0.5× 212 1.3× 17 0.3× 45 987
Brad O. Buckman United States 19 391 0.5× 169 0.6× 123 0.5× 407 2.5× 87 1.3× 37 986
Joachim Blanz Germany 14 536 0.6× 202 0.7× 123 0.5× 183 1.1× 40 0.6× 31 967
Xiang-ju Gu United States 11 522 0.6× 197 0.7× 55 0.2× 116 0.7× 23 0.4× 12 911
Agustı́n Rodrı́guez-González Spain 16 859 1.0× 282 1.0× 72 0.3× 97 0.6× 20 0.3× 25 1.3k
Dale Grabowski United States 22 1.1k 1.3× 650 2.3× 124 0.5× 157 1.0× 42 0.6× 67 1.4k
James M. Hamby United States 17 542 0.7× 121 0.4× 53 0.2× 349 2.2× 46 0.7× 32 828
Keith Menear United Kingdom 17 1.1k 1.3× 778 2.7× 56 0.2× 393 2.4× 32 0.5× 32 1.6k

Countries citing papers authored by Yasuhiro Imaeda

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Imaeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Imaeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Imaeda more than expected).

Fields of papers citing papers by Yasuhiro Imaeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Imaeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Imaeda. The network helps show where Yasuhiro Imaeda may publish in the future.

Co-authorship network of co-authors of Yasuhiro Imaeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Imaeda. A scholar is included among the top collaborators of Yasuhiro Imaeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Imaeda. Yasuhiro Imaeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nogami, Masahiro, Misa Iwatani, Toshihiro Imaeda, et al.. (2020). Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays. Biochemical and Biophysical Research Communications. 523(3). 795–801. 10 indexed citations
2.
Ito, Masahiro, Toshio Tanaka, Noriko Uchiyama, et al.. (2018). Discovery of 3-Benzyl-1-(trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. Journal of Medicinal Chemistry. 61(17). 7710–7728. 51 indexed citations
3.
Imaeda, Yasuhiro, Yoshiyuki Fukase, Koichi Iwanaga, et al.. (2018). Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. Bioorganic & Medicinal Chemistry. 26(12). 3261–3286. 6 indexed citations
4.
Ohoka, Nobumichi, Katsunori Nagai, Kenichiro Shimokawa, et al.. (2018). Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation. Journal of Biological Chemistry. 293(18). 6776–6790. 84 indexed citations
5.
Ito, Masahiro, Toshio Tanaka, Douglas R. Cary, et al.. (2017). Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors. Journal of Medicinal Chemistry. 60(8). 3335–3351. 28 indexed citations
6.
Yasui, Takeshi, Takeshi Yamamoto, Nozomu Sakai, et al.. (2017). Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design. Bioorganic & Medicinal Chemistry. 25(17). 4876–4886. 21 indexed citations
7.
Ito, Masahiro, Yoshihiro Ishibashi, Hideyuki Oki, et al.. (2017). Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay. ACS Chemical Biology. 12(7). 1760–1768. 30 indexed citations
8.
Ohoka, Nobumichi, Keiichiro Okuhira, Masahiro Ito, et al.. (2017). In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs). Journal of Biological Chemistry. 292(11). 4556–4570. 193 indexed citations
9.
Ito, Masahiro, Misa Iwatani, Yusuke Kamada, et al.. (2017). Discovery of selective ATP-competitive eIF4A3 inhibitors. Bioorganic & Medicinal Chemistry. 25(7). 2200–2209. 26 indexed citations
10.
Imaeda, Yasuhiro, Michiko Tawada, Mitsuyo Kondo, et al.. (2016). Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 5771–5780. 11 indexed citations
11.
Sakamoto, Kotaro, Satoshi Sogabe, Yusuke Kamada, et al.. (2016). Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship. Biochemical and Biophysical Research Communications. 482(2). 310–316. 26 indexed citations
12.
Tawada, Michiko, Yasuhiro Imaeda, Hideyuki Oki, et al.. (2016). Novel approach of fragment-based lead discovery applied to renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 6066–6074. 6 indexed citations
13.
Højfeldt, Jonas W., et al.. (2014). Bifunctional Ligands Allow Deliberate Extrinsic Reprogramming of the Glucocorticoid Receptor. Molecular Endocrinology. 28(2). 249–259. 2 indexed citations
14.
Tanaka, Yuta, Katsuji Aikawa, Goushi Nishida, et al.. (2013). Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins. Journal of Medicinal Chemistry. 56(23). 9635–9645. 91 indexed citations
15.
Kawamura, Masaki, et al.. (2010). Antithrombotic and Anticoagulant Profiles of TAK-442, a Novel Factor Xa Inhibitor, in a Rabbit Model of Venous Thrombosis. Journal of Cardiovascular Pharmacology. 56(2). 156–161. 10 indexed citations
16.
Imaeda, Yasuhiro, Hiroki Sakamoto, Fumio Itoh, et al.. (2007). Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors. Bioorganic & Medicinal Chemistry. 16(5). 2243–2260. 12 indexed citations
17.
Imaeda, Yasuhiro, Tetsuji Kawamoto, Noriko Konishi, et al.. (2007). Discovery of piperazinylimidazo[1,2-a]pyridines as novel S4 binding elements for orally active Factor Xa inhibitors. Bioorganic & Medicinal Chemistry. 16(6). 3125–3140. 15 indexed citations
18.
Hori, Akira, Yasuhiro Imaeda, Keiji Kubo, & Masami Kusaka. (2002). Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo. Cancer Letters. 183(1). 53–60. 27 indexed citations
19.
Sawa, Masaaki, Yasuhiro Imaeda, Jun Hiratake, et al.. (1998). Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten. Bioorganic & Medicinal Chemistry Letters. 8(6). 647–652. 7 indexed citations
20.
Miyoshi, Hideto, Nobuya Tokutake, Yasuhiro Imaeda, T. Akagi, & Hajime Iwamura. (1995). A model of antimycin A binding based on structure-activity studies of synthetic antimycin A analogues. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1229(2). 149–154. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026